ALPMF - Astellas Pharma GAAP EPS of ¥67.20 revenue of ¥1.18B
2024-02-05 08:06:35 ET
More on Astellas Pharma
- Astellas Pharma Inc. 2023 Q3 - Results - Earnings Call Presentation
- FDA denies approval of Astellas gastric cancer drug
- Astellas and Elpiscience collaborate for novel bi-specific macrophage engagers
- Historical earnings data for Astellas Pharma
- Dividend scorecard for Astellas Pharma